Previous Close | 41.24 |
Open | 41.24 |
Bid | 43.00 |
Ask | 44.05 |
Strike | 87.50 |
Expire Date | 2025-01-17 |
Day's Range | 41.24 - 41.24 |
Contract Range | N/A |
Volume | |
Open Interest | 91 |
Merck has said it's in the market for deals of up to around $15 billion as it plans ways to deal with a loss of revenue from its aging cancer immunotherapy Keytruda.
Investing.com-- Merck&Company Inc (NYSE:MRK) is close to entering a $1.3 billion deal to buy Eyebiotech, granting the pharmaceutical giant entry into the rapidly growing eyecare market, the Wall Street Journal reported on Tuesday.
RAHWAY, N.J., May 28, 2024--Merck Announces Third-Quarter 2024 Dividend